Global Medical Cannabis Market Review
Due for publication in January 2026, the Global Medical Cannabis Market Review will examine the status and dynamics of the international medical cannabis supply chain, highlighting emerging developments and trends in key international markets. It will provide country-specific data, comparing countries based on relevant metrics including volumes of exports and imports, market size, domestic production, product and distribution landscape. The Review will delve deeper into the driving forces behind international import and supply chain dynamics, as well as factors such as: domestic production capabilities in various countries, the impact of telemedicine on patient access and care, and recent regulatory changes that shape the landscape of medical cannabis. By analysing these elements, the Review aims to offer insights into market growth potential and the evolving global context of medical cannabis supply and demand. Data packs are now available to pre-order and will be delivered digitally in January 2026. You can also pre-register your interest in the full free report by clicking the button below.
- Executive Summary & Introduction
- Global Medical Supply Chain Overview
- Exporter Country Snapshots
- Canada
- Portugal
- Denmark
- North Macedonia
- Spain
- Australia
- Czech Republic
- South Africa
- Thailand
- Patient Market Snapshots
- Australia
- Germany
- UK
- Poland
- Brazil
- France
- Themes being covered throughout the report include:
- Canada’s impact on international markets
- TelemedicineÂ
- Opening of medical markets
- Import quota increases/decreases
- Conclusion
Global Medical Cannabis Market Review
Due for publication in January 2026, the Global Medical Cannabis Market Review will examine the status and dynamics of the international medical cannabis supply chain, highlighting emerging developments and trends in key international markets. It will provide country-specific data, comparing countries based on relevant metrics including volumes of exports and imports, market size, domestic production, product and distribution landscape. The Review will delve deeper into the driving forces behind international import and supply chain dynamics, as well as factors such as: domestic production capabilities in various countries, the impact of telemedicine on patient access and care, and recent regulatory changes that shape the landscape of medical cannabis. By analysing these elements, the Review aims to offer insights into market growth potential and the evolving global context of medical cannabis supply and demand. Data packs are now available to pre-order and will be delivered digitally in January 2026. You can also pre-register your interest in the full free report by clicking the button below.
Medical Market Sizing - Key International Markets
-This market sizing package includes a raw spreadsheet of market sizing and patient population forecasts for 14 key international markets - from 2026-20230. Also included is graphical and narrative analysis of the market size and the driving forces behind growth. In addition, scenario forecasting for Australia & Germany will also be included.
15% Off - £1,742
UK & Germany Medical Distributor Portfolios (Product Count)
-Evolution of Distributor Product Portfolios
15% Off - £1,381
UK & Germany (Product & Pricing Analysis)
-- Monthly pricing development of products
- Average Pricing by month and product format
15% Off - £1,589
Export/Import Comparison (Key Markets)
-- Key Market Import/Export Volumes
- Export market comparison
- Import market comparison
15% Off - £1,075
Average Price Evolution – UK & Germany Comparison
-15% Off - £1,130
PARTNERS
OVERVIEW
KEY FINDINGS
Data Packages
As Trusted By
Insights
on the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.